【结 构 式】 |
【药物名称】NSC-697726, RH1 【化学名称】2,5-Di(1-aziridinyl)-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone 【CA登记号】221635-42-3 【 分 子 式 】C12H14N2O3 【 分 子 量 】234.25698 |
【开发单位】Cancer Research UK (Originator), National Cancer Institute (Originator) 【药理作用】Oncolytic Drugs, Solid Tumors Therapy, DNA-Damaging Drugs |
合成路线1
2-(Hydroxymethyl)-5-methyl-1,4-benzoquinone (III) was obtained by hydroxymethylation of toluhydroquinone (I) with formaldehyde, followed by oxidation of the resulting hydroquinone (II) with Ag2O. Then, addition of aziridine (IV) to quinone (III) furnished the title compound.
【1】 Remers, W.A.; Witty, T.R.; Synthesis and antitumor and antibacterial activity of benzoquinones related to the mitomycins. J Med Chem 1973, 16, 11, 1280. |
【2】 Winski, S.L.; Hargreaves, R.H.J.; Butler, J.; Ross, D.; A new screening system for NAD(P)H: quinone oxidoreductase (NQO1)-directed antitumor quinones: Identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent. Clin Cancer Res 1998, 4, 12, 3083. |
Extended Information